Just like you, a dermatologist used to be overwhelmed by skincare products. Here's her simple anti-aging routine.

Even dermatologists can find the skincare world intimidating to wade through.
Dr. Suchismita "Tia" Paul, a board-certified dermatologist in Newport Beach, California, said her professional training helped her understand which products actually worked. Prior to that, "I was always very confused, too," Paul, 38, told Business Insider.
She learned that it's precisely that pressure to pile on enough anti-aging ingredients — vitamin C, retinol, niacinamide, hyaluronic acid, peptides, ceramides — that can cause skin irritation and breakouts.
Paul is active on social media to help demystify the skincare world. In one video, she speaks with Mindy Kaling about toning down retinol use.
"My biggest takeaway is keeping it simple," she said. "Not having too many steps, especially if you don't know what each serum is meant to do."
Paul broke down her simple daytime and nighttime skincare routine step-by-step, including which products she swaps out seasonally.
4-step morning skincare routine:
She washes her face with a gentle cleanser (La Roche-Posay Toleriane Purifying Foaming Cleanser).
She applies a "treatment," usually vitamin C serum (cult-favorite $182 Skinceuticals C E Ferulic or the more affordable $35 version from Timeless Skin Care) to target brown spots. Sometimes, she swaps the vitamin C with niacinamide (Paula's Choice Niacinamide 20% Treatment) if her skin feels red or dry.
Paul said this step varies depending on your personal skin needs. For example, if you have acne, you'll want to use a serum with salicylic acid.
She tops with a hydrating moisturizer (CeraVe Daily Moisturizing Lotion or Neutrogena Hydro Boost Water Gel). She likes these because they're affordable and have hydrating ingredients like ceramides and hyaluronic acid.
Lastly, she applies tinted sunscreen (Supergoop Glowscreen SPF 40). "I don't wear much makeup, so I find that very nice because it just leaves a little glow," she said. She also likes the tinted options from La Roche-Posay and EltaMD.
4-step nighttime skincare routine
Paul starts by double-cleansing, first with an oil-based cleanser (Clinique Take The Day Off Cleansing Balm) to remove sunscreen and eye makeup. She then finishes with her morning cleanser (La Roche-Posay Toleriane Purifying Foaming Cleanser).
She uses either a prescription-strength retinoid (tretinoin), which increases cell turnover and boosts collagen production for more youthful-looking skin. When her skin is feeling sensitive, she instead uses a gentler, over-the-counter retinol (Murad Retinol Youth Renewal Firming & Smoothing Serum with Hyaluronic Acid). "I've been using tretinoin for 10 years — even then, I cannot do it every single night," she said.
She applies the same moisturizer she used in the morning (CeraVe Daily Moisturizing Lotion or Neutrogena Hydro Boost Water Gel).
The last step is an eye cream (Dr. Dennis Gross Skincare DermInfusions Fill + Repair Eye Cream) to hydrate her under-eye area more.
She also exfoliates and practices skin-cycling
Paul exfoliates her skin a few times a week to unclog her pores and soften her skin. After cleansing her skin in the morning, she applies a chemical exfoliant (Paula's Choice 2% BHA Liquid Exfoliant) or a scrub (ZO Skin Health Exfoliating Polish). She said which one you use should be "based on how sensitive or dry your skin feels." After that step, she adds moisturizer and sunscreen, omitting any serums that could irritate her skin.
She also changes her skincare routine depending on the season. In the winter, when her skin feels drier, she'll take breaks from retinol and vitamin C (which can be irritating). Instead, she uses snail mucin (COSRX Advanced Snail 96 Mucin Power Essence) or a hyaluronic acid serum (La Roche-Posay Hyalu B5 Hyaluronic Acid Serum) for extra hydration.
If you're just starting out with a skincare routine, she emphasized being consistent as well as patient with the results. "I've been doing this for so long and now, yes, I feel like my skin is super nice and soft," she said. "But for the first couple of months, you're not going to see the effects right away."

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Miami Herald

4 hours ago

• Miami Herald

The diet mistake 71% of Americans are trying to fix

For the last two years, I've been that girl. The one with the food scale permanently parked on her kitchen counter. The one who actually tracks her meals - not to eat less, but to make sure she's getting enough of one specific thing. Because somewhere along the way, I realized I was doing something a lot of people do. I was eating "healthy," but not actually fueling my body. Related: General Mills makes huge change to your favorite cereals I'd grab a smoothie, a salad, a grain bowl. All the wellness-y things. But I'd still feel tired. Hungry an hour later. And weirdly bloated for no reason. So I started measuring. I started checking labels. And what I noticed was that this one macronutrient was way too low most days. Now, I build my meals around it. And it turns out I'm not the only one making this shift. This isn't exactly breaking news. The protein push has been quietly bulking up for a while now. According to the 2024 IFIC Food and Health Survey, the number of Americans who say they're actively trying to consume more protein has jumped from 59% in 2022 to 71% in 2024. That's a huge increase. And it tracks with what you're seeing in grocery aisles, TikTok meal prep videos, and even high-end wellness brands. Everyone is leaning into protein - not just for muscle, but for energy, satiety, and overall health. "Protein isn't just for bodybuilders, it's for everyone…protein helps repair cells, build connective tissue, and strengthen immune cells," Dr. Rupy Aujla told Business Insider. Aujla also points out that official protein guidelines are "set far too low" and most of us are falling short without even realizing it. everyone agrees. Related: WeightWatchers takes drastic step to exit bankruptcy Some health experts say Americans already get plenty of protein and should focus more on fiber and vegetables. Others caution that too much protein can displace other important nutrients. No matter what the experts say, I can only speak from my own experience, and I've personally felt a noticeable difference from eating more protein. I'm more energized, I stay full longer, and my workouts and recovery have improved. Let's just say the protein gains are I'm not mad about it. If you're protein-curious, the good news is it's easy to level up. Simple swaps like plain Greek yogurt instead of sugary yogurt, adding eggs or turkey to breakfast, or doubling the beans in your salad can make a big difference. And now that brands are paying attention, it's easier than ever to find higher-protein options in every category. The consumer shift hasn't gone unnoticed. High-protein products are everywhere in 2025, from protein-enriched pastas and pancake mixes to bars, drinks, and even pizza crusts. It's not just a health store trend anymore; mainstream grocery shelves are packed with options aimed at helping shoppers get more protein without overhauling their diets. Catalina Crunch Cereal (a personal fave), Ripple Protein Milk, and Egglife Wraps are all built around high-protein claims. Even restaurant chains are getting in on it: Sweetgreen lets you double your protein, and Starbucks has quietly added more egg and cheese-heavy breakfast items to meet demand. And it's not just niche - this is a huge market that's expected to significantly expand. According to Technavio, the global protein market is projected to grow by $50.2 billion between 2024 and 2028. The Associated Press summed it up perfectly in a recent article: the "proteinization" of food is here to stay. High-protein offerings have expanded far beyond gyms and specialty stores, becoming a staple in everyday products as more consumers prioritize fullness, energy, and long-term health. Protein isn't just for macro trackers and gym bros anymore. It's gone fully mainstream. Because it's good news if something as simple as adding a few more grams to your meals can help you feel more full, support your workouts, and keep your energy up. Related: How psychedelic mushrooms are helping people unlock their potential The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

Yahoo

4 hours ago

• Yahoo

[Latest] Global Alzheimer's Drug Market Size/Share Worth USD 19.3 Billion by 2034 at a 13.03% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Alzheimer's Drug Market size & share revenue was valued at approximately USD 5.64 Billion in 2024 and is expected to reach USD 6.41 Billion in 2025 and is expected to reach around USD 19.3 Billion by 2034, at a CAGR of 13.03% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Eli Lilly and Co., Biogen Inc., Roche Holding AG, AstraZeneca PLC, Novartis AG, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Bayer AG, Amgen Inc., Sanofi S.A., AbbVie Inc., Takeda Pharmaceutical Company Limited, Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Acadia Pharmaceuticals Inc., Alzheon Inc., Cassava Sciences Inc., Green Valley Pharmaceutical Inc, and others. Austin, TX, USA, June 23, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'Alzheimer's Drug Market Size, Trends and Insights By Type of Drug (Disease-Modifying Therapies (DMTs), Symptomatic Therapies), By Application (Amyloid-Targeting Agents, Tau-Targeting Agents, Cholinesterase Inhibitors, NMDA Antagonists, Other Agents), By End User (Hospitals, Clinics, Home Care Settings), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' in its research database. 'According to the latest research study, the demand of the global Alzheimer's Drug Market size & share was valued at approximately USD 5.64 Billion in 2024 and is expected to reach USD 6.41 Billion in 2025 and is expected to reach a value of around USD 19.3 Billion by 2034, at a compound annual growth rate (CAGR) of about 13.03% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global Alzheimer's Drug Market @ Alzheimer's Drug Market Overview As per the industry experts at CMI, the market for Alzheimer's Drugs includes the ageing global population, rising awareness about the disease, and advancements in disease-modifying therapies (DMTs). Increased investments in research and demand for effective treatments further fuel the market growth, thus offering opportunities for pharmaceutical firms. Alzheimer's Drug Market Growth Factors and Dynamics Aging Population: The global aging population is a growth driver for the Alzheimer's drug market. With an ever-growing proportion of elderly individuals, the disease is becoming more and more prevalent. This demographic shift, especially in North America, Europe, and Asia-Pacific, is triggering the demand for innovative therapies. Alzheimer's disease primarily affects individuals aged 65 and above, and as the elderly population grows, it will significantly expand the patient base. The more serious implications of this trend include an immediate need for effective disease-modifying therapies, which presents a possible opportunity in the coming years. Thus, the rise in Alzheimer's cases combined with an aging population offers an opportunity for substantial growth in the market. Trends Influencing Research and Development: Advancements in mechanisms in research for Alzheimer's disease are accelerating the development of new and more effective therapies. Key discoveries about drugs that target amyloid, therapies based on tau, and genetic research are paving the way for treatments that can change the course of the disease. The improved understanding of Alzheimer's pathology has led to the ability to direct drug compounds against the underlying disease instead of merely alleviating symptoms. Large-scale clinical trials, supported by significant investments from both private and government sectors, will drive significant growth in R&D over the next few years by introducing new treatment options. Elevated Investments and Awareness in Healthcare: Increasing recognition of Alzheimer's disease as a growing healthcare challenge has, of course, led to increasing investment in research, treatment, and supportive services. Governments, healthcare organizations, and the private sector are spending more money developing better ways to treat people. There is also a greater commitment to addressing Alzheimer's disease expressed in policy changes, increased funding for clinical trials, and public health initiatives aimed at early diagnosis and intervention. The rise in awareness concerning the said Alzheimer's disease will also make it possible for healthcare providers and patients to seek and adopt new treatments more widely, thus feeding market demand. Request a Customized Copy of the Alzheimer's Drug Market Report @ High Treatment Costs and Accessibility Issues: The advanced Alzheimer's drug market deals with the high costs of disease-modifying therapy, which are some of the biggest challenges to disease-modifying therapies (DMTs). Annual treatment costs for amyloid-targeting agents, especially Aducanumab, are at a rate of over $50,000. Such prices may deny access to new treatments, mostly in the setting of the developing world healthcare systems or where insurance coverage is scant. While new therapies play their part in modifying the disease, affordability or cost will remain a major dynamic in the adoption rate. Combined with the necessity for frequent diagnostic imaging, high treatment costs will probably prevent the market from expanding access to all patient populations. Approval Delays and Regulatory Hurdles: Regulatory processes define the drug market for Alzheimer's because any drug needs to go through extensive clinical trials and approval procedures before its market entry. Regulatory authorities, such as the FDA and EMA, are becoming more cautious due to the complexity of treatments and the risks associated with new therapies for Alzheimer's. Concerns about side effects, including brain swelling associated with amyloid-targeting agents, often lead to extended approval times and heightened safety concerns. These regulatory dynamics will often end up delaying entry into the market for promising treatments, which in turn slows down market growth and the availability of new drugs. Market Fragmentation and Competitive Landscape: The Alzheimer's drug market is said to be highly fragmented, with more and more entrants coming in to offer competition for developing therapeutic options. While major companies like Eli Lilly, Biogen, and Roche have established themselves as market leaders with therapies targeting amyloid, they face competition from small biotechnology firms that are focusing on unique targets such as tau proteins and other mechanisms of Alzheimer's disease. Competition here, however, generates innovation but also creates difficulties in differentiating products. The plethora of divergent mechanisms and efficacy profiles would confuse, among other things, healthcare providers and patients, making it harder for individual therapies to capture the market. Report Scope Feature of the Report Details Market Size in 2025 USD 6.41 Billion Projected Market Size in 2034 USD 19.3 Billion Market Size in 2024 USD 5.64 Billion CAGR Growth Rate 13.03% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Type of Drug, Application, End User and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the Alzheimer's Drug report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: The updated report for 2024 includes an Introduction, an Overview, and an in-depth industry analysis. We have included the COVID-19 Pandemic Outbreak Impact Analysis in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes We have updated the tables and figures. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the Alzheimer's Drug report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the Alzheimer's Drug Market Report @ Alzheimer's Drug Market SWOT Analysis Strengths: The Alzheimer's drug market is now almost purely dependent on huge R&D investments directed toward disease-modifying therapies. Breakthrough therapies in the shape of amyloid-targeting drugs have gained so much attention. However, the tremendous global aging population plays a significant role in market growth because these individuals will certainly require treatment for Alzheimer's disease. More regulatory developments are leaning toward the faster approval of therapies with encouraging promise. Growing awareness and concern over Alzheimer's as a public health issue have facilitated research funding, clearing the path toward advanced treatment options. Weaknesses: The cost of new treatments, like Aducanumab, is a major weakness in the Alzheimer's drug market; they cannot be reached. This cost acts as a barrier to introducing it more widely in health economies with a limited budget. Also, the existence of safety issues related to the newer modalities, like brain swelling or bleeding, limits the number of patients eligible for the treatment. While many advances have been made, the treatments remain essentially symptomatic or limited in effect, leading to reluctance on the part of both patients and healthcare providers to use these therapies. Opportunities: The increasing number of Alzheimer's disease diagnoses presents significant opportunities for the Alzheimer's drug market. The demand for innovative treatments rises with an increasing patient population. Another opportunity is offered by advances in the area of personalized medicine and genetic therapies, with the prospect of tailoring therapies to individual patients. Research on Alzheimer's disease is receiving an increasing amount of funding, and increasing awareness of this disease presents additional growth opportunities. There also arise major opportunities for developing low-cost therapies, with better access to healthcare infrastructure in developing markets, such as those in the Asia-Pacific region and Latin America. Threats: Regulatory obstacles to the approval of new therapies pose the primary threat to entry into the Alzheimer's drug market. Strict rules for clinical trials make it hard for new drugs to enter the market and raise concerns about the safety of drugs in the later trial stages, especially those aimed at amyloid. High costs of treatment represent another challenge, especially for patients in low-income areas or those lacking comprehensive health insurance coverage. The development of several treatments could fragment the market, leading to increased competition and making it difficult for individual therapies to take hold. Another factor impeding market growth is the regulatory backlash against new drugs based on safety issues. Request a Customized Copy of the Alzheimer's Drug Market Report @ Key questions answered in this report: What is the size of the Alzheimer's Drug market and what is its expected growth rate? What are the primary driving factors that push the Alzheimer's Drug market forward? What are the Alzheimer's Drug Industry's top companies? What are the different categories that the Alzheimer's Drug Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the Alzheimer's drug market sample and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium Alzheimer's Drug Research Report | Fast Delivery Available - [220+ Pages] @ Alzheimer's Drug Market Regional Analysis The Alzheimer's drug market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region: North America: North America, especially the United States, accounts for the largest portion of the Alzheimer's drug market as a result of the aging population, extensive health care expenditure, and all the research and development activities going on. Major pharmaceutical companies like Eli Lilly, Biogen, and Johnson & Johnson are present in the country and are at the forefront of developing DMTs for Alzheimer's disease. Moreover, the North American region boasts well-established healthcare infrastructures that will facilitate the adoption of new therapies. The rapid uptake of drugs targeting amyloid, like Aducanumab, reflects the growing consumer demand for innovative treatments. The economic accessibility of these treatments is narrowing down for the older population. The high cost of these therapies, combined with growing concerns about affordability and healthcare access, presents significant challenges to their widespread use. North America has emerged as the largest and fastest-growing market in terms of increasing demand for new treatments and the rising number of Alzheimer's patients. Europe: The continent of Europe will play a significant role in the development of Alzheimer's drugs worldwide as it benefits from sound healthcare systems, high prevalence of the disease, and major research funding. Countries such as Germany, the United Kingdom, and France all boast solid healthcare access and traditional treatment and new approval streams. The authorizing of new indications for many novel therapies has even been possible in Europe, in particular by the European Medicines Agency (EMA), which recently cleared Leqembi and Aducanumab. Asia-Pacific: The market for Alzheimer's drugs in the Asia-Pacific region is, according to analysts, the most rapidly growing. The stupendous aging populations in Japan, China, and India play their part. In addition to the anticipated improvements from infrastructure and government programs, the region is enhancing its healthcare access. Given that Japan is one of the oldest populations in the world, it serves as a great opportunity market for drugs for Alzheimer's patients-such as those at the early stage of their disease. Thus, the developing awareness of Alzheimer's disease will also increase the application of diagnostic technologies regarding necromancy, and the need for advancing therapies to change the course of the disease is increasing. The fact that increasingly expensive alternatives to treatment are becoming more widely prescribed is unlikely to prevent use. LAMEA (Latin America, the Middle East, and Africa): Latin America, the Middle East, and Africa (LAMEA) have unique market dynamics. For example, among the Latin American countries, Brazil and Mexico are likely to experience increased demand for Alzheimer's treatments because of their aging populations and growing awareness regarding the disease. However, it has also been limited by the economic situation and the commonly inaccessible aspects of healthcare or budget constraints. The increased incidences of Alzheimer's are creating a need for more treatment options in the Middle East, such as in the UAE and Saudi Arabia, but high costs of drugs remain a major hurdle. Unfortunately, Africa faces the same issues, specifically a lack of population-wide tools for facilitating diagnosis and healthcare infrastructure. Request a Customized Copy of the Alzheimer's Drug Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do you want data for inclusion in magazines, case studies, research papers, or media? Email Directly Here with Detail Information: support@ Browse the full 'Alzheimer's Drug Market Size, Trends and Insights By Type of Drug (Disease-Modifying Therapies (DMTs), Symptomatic Therapies), By Application (Amyloid-Targeting Agents, Tau-Targeting Agents, Cholinesterase Inhibitors, NMDA Antagonists, Other Agents), By End User (Hospitals, Clinics, Home Care Settings), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' Report at Leading Players: Eli Lilly and Co. Biogen Inc. Roche Holding AG AstraZeneca PLC Novartis AG Johnson & Johnson Pfizer Inc. Merck & Co. Inc. Bayer AG Amgen Inc. Sanofi S.A. AbbVie Inc. Takeda Pharmaceutical Company Limited Lundbeck A/S Otsuka Pharmaceutical Co. Ltd. Lundbeck A/S Acadia Pharmaceuticals Inc. Alzheon Inc. Cassava Sciences Inc. Green Valley Pharmaceutical Inc. Others Click Here to Access a Free Sample Report of the Global Alzheimer's Drug Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures We offer a subscription-based option. Best price guarantee We offer free 35% or 60 hours of customization. We also offer free post-sale service assistance. You will receive a 25% discount on your subsequent purchases. Service guarantees are available. The author will create a customized market brief for you. Browse More Related Reports: Cell and Gene Therapy Market: Cell and Gene Therapy Market Size, Trends and Insights By Therapy Type (Cell Theray, Gene Therapy), By Therapeutic Class (Cardiovascular Disease, Cancer, Genetic Disorder, Rare Diseases, Oncology, Hematology, Ophthalmology, Infectious Disease, Neurological Disorders, Others), By Delivery Method (In Vivo, Ex Vivo), By End-User (Hospitals, Cancer Care Centers, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Battery-Free Implants Market: Battery-Free Implants Market Size, Trends and Insights By Product Type (Neural Implants, Cardiac Implants , Cochlear Implants, Orthopedic Implants, Others), By Technology (Energy Harvesting, Wireless Power Transfer, RFID/NFC-based Systems), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutions, Specialty Clinics), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Japan Cell Cancer Vaccine Market: Japan Cell Cancer Vaccine Market Size, Trends and Insights By Vaccine Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines, Oncolytic Viruses), By Indication (Prostate Cancer, Cervical Cancer), By Technology (Peptide-based Vaccines, Vector-based Vaccines, DNA/RNA-based Vaccines), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 mRNA Cancer Vaccine Market: mRNA Cancer Vaccine Market Size, Trends and Insights By Cancer Type (Melanoma, Lung Cancer (NSCLC), Prostate Cancer, Pancreatic Cancer, Colorectal Cancer), By Application/Use Case (Therapeutic Cancer Vaccines, Preventive/Prophylactic Cancer Vaccines), By Delivery Mechanism (Lipid Nanoparticles (LNPs), Polymer-Based Carriers, Electroporation), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Neoantigen Cancer Vaccine Market: Neoantigen Cancer Vaccine Market Size, Trends and Insights By Product (Personalised antigen vaccine, Off-the-shelf neoantigen vaccine), By Neoantigen Type (Synthetic Long Peptide, Nucleic acid, Dendritic cell, Tumour cell), By Route of Administration (Intravenous, Intramuscular, Transdermal), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Peptide Cancer Vaccine Market: Peptide Cancer Vaccine Market Size, Trends and Insights By Type (Multivalent Peptide Vaccine, Peptide Cocktail Type, Personalized Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine, Hybrid Peptide Vaccine), By Application (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 US Pharmaceutical Drug Delivery Market: US Pharmaceutical Drug Delivery Market Size, Trends and Insights By Route of Administration (Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other), By Application (Cardiovascular Diseases, Diabetes, Cancer, Infectious Diseases, Others), By End-user (Hospitals, Ambulatory Services, Home Healthcare), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 High Flow Nasal Cannula Market: High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single Heated Tube, Nasal Cannula, Active Humidifier, Air Blender), By Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart Failure, Others), By End User (Hospitals and Clinics, Ambulatory Care Centers, Long-term Care Centers, Others), By Sales Channel (Direct Channel, Indirect Channel), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 The We have segmented the Alzheimer's Drug Market as follows: By Type of Drug Disease-Modifying Therapies (DMTs) Symptomatic Therapies By Application Amyloid-Targeting Agents Tau-Targeting Agents Cholinesterase Inhibitors NMDA Antagonists Other Agents By End User Hospitals Clinics Home Care Settings Click Here to Get a Free Sample Report of the Global Alzheimer's Drug Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This Alzheimer's Drug Market Research/Analysis Report contains answers to the following questions: Which Trends Are Causing These Developments? Who Are the Global Key Players in This Alzheimer's Drug Market? What are the company profiles, product information, and contact details for these key players? What Was the Global Market Status of the Alzheimer's Drug Market? What Was the Capacity, Production Value, Cost and PROFIT of the Alzheimer's Drug Market? What Is the Current Market Status of the Alzheimer's Drug Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's the Market Analysis of Alzheimer's Drug Market by Considering Applications and Types? What Are Projections of the Global Alzheimer's Drug Industry Considering Capacity, Production, and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply, and Consumption? What about imports and exports? What Is Alzheimer's Drug Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On Alzheimer's Drug Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of Alzheimer's Drug Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Alzheimer's Drug Industry? Click Here to Access a Free Sample Report of the Global Alzheimer's Drug Market @ Reasons to Purchase Alzheimer's Drug Market Report Alzheimer's Drug Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. Alzheimer's Drug Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. Alzheimer's Drug Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. The report includes extensive company profiles, which include company overviews, insights, product benchmarking, and SWOT analyses for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. Alzheimer's Drug Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and offers context for the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the global Alzheimer's Drug market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established leaders drive market growth. Buy this Premium Alzheimer's Drug Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Alzheimer's Drug market analysis. The report covers the competitive environment of current and potential participants in the Alzheimer's Drug market, along with those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. The report provides actual market sizes and forecasts for each segment mentioned above. Who should buy this report? Participants and stakeholders worldwide Alzheimer's Drug market should find this report useful. The research will be useful to all market participants in the Alzheimer's Drug industry. Managers in the Alzheimer's Drug sector are interested in publishing up-to-date and projected data about the worldwide Alzheimer's Drug market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Alzheimer's Drug products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the Alzheimer's Drug Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work toward achieving sustainable growth in their respective domains. CMI offers a comprehensive solution, from data collection to investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts apply client insights on aspects such as strategies for future estimation falls, forecasting or opportunities to grow, and consumer surveys. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium Alzheimer's Drug Research Report | Fast Delivery Available - [220+ Pages] @ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Business Insider

8 hours ago

• Business Insider

3 simple recipes that make eating fewer ultra-processed foods easy, by a nutritionist

Ultra-processed foods have been linked to health issues such as cardiovascular disease and cancer. While they can be convenient, they should be eaten in moderation, a nutritionist said. Rhiannon Lambert shared recipes for granola, flatbreads, and chocolate peanut bars. In recent years, ultra-processed food has been the subject of endless news reports, books, and online debate. But while research increasingly points to the potential health risks of UPFs, including cardiovascular disease and cancer, they shouldn't necessarily be demonized, the UK-based registered nutritionist Rhiannon Lambert told Business Insider. Processing food can preserve it better, or make it more accessible, she said. "I think UPFs have a place, but they should not be consumed as frequently as they are, and they have become a problem in the sense that most people are now missing out on whole foods by opting for ultra-processed foods instead," Lambert said. In her new book, "The Unprocessed Plate: Simple, Flavourful UPF-free Recipes to Transform Your Life," Lambert explains what people need to know about UPFs and shares recipes to help you eat fewer of them. Below are three recipes that are easy to make from scratch so you can avoid buying ultra-processed versions. Easy yogurt flatbreads "These flatbreads are such a useful recipe to have up your sleeve, and you can use whatever flour you have to hand. Each type of yogurt and flour has different hydration levels, so this recipe is just a guide — if you find the dough is too dry, add splashes of water until it comes together; if you find it's too wet, simply add more flour," Lambert wrote. She continued: "Once you've got the hang of the basic recipe, feel free to experiment by adding some of the optional extras to the dough. The flatbreads are also delicious brushed with a little melted butter as they come out of the pan." Prep: 10 minutes Cook: 10 minutes Nutrition per portion: Fiber: 3.1 grams Protein: 13 grams Ingredients: 400 grams (3 cups/14 ounces) white spelt or wholemeal flour, plus extra to dust 1 tablespoon baking powder 1 teaspoon sea salt 1 teaspoon olive oil, plus extra for frying if needed 200 grams (1 cup/7 ounces) skyr, Greek yogurt, or coconut yogurt Optional extras: Freshly ground black pepper Grated garlic Nigella seeds Cumin seeds Chopped coriander (cilantro) leaves Sliced spring onion (scallion) Desiccated (dried, shredded) coconut Method: 1. Combine the flour, baking powder, and salt in a bowl, then stir in the olive oil and yogurt (add any additional extras now, too). Mix with your hands until the dough comes together, then tip onto a flour-dusted surface and knead for a couple of minutes until you have a smooth dough. Divide the dough into six equal balls, cover with a clean tea (dish) towel, and allow to rest for at least 10 minutes. 2. Meanwhile, set a griddle pan or non-stick frying pan (skillet) over a high heat. 3. Roll each dough ball into a flatbread shape about 20 centimeters (eight inches) long and two millimeters (1⁄8 inch) thick. If your pan isn't non-stick or you want a slightly crisp finish to your flatbreads, brush both sides of the flatbreads with a little olive oil. 4. When the pan is searingly hot, add a flatbread to the pan and cook for 60 to 90 seconds until char marks appear, then flip it over and cook the other side until nicely charred too. Wrap the flatbread in a tea (dish) towel while you cook the rest. Seedy granola "This is such an adaptable recipe that you can make based on what you have in your store cupboard or your personal preferences for flavor and crunch. I love it, as it provides my family and me with lovely healthy fats and fibre for the day ahead. Serve as it is with your preferred milk, or top with fresh fruit and yogurt," Lambert said. Prep: 25 minutes Cook: 40 minutes Nutrition per 40-gram portion: Fiber: 3.3 grams Protein: 5.3 grams Ingredients: 175 grams (6.5 ounces) jumbo oats 175 grams (6.5 ounces) barley, spelt, or rye flakes (or simply use more jumbo oats) 150 grams (5.5 ounces) nuts, roughly chopped (I use a mix of almonds, hazelnuts, pecans, and walnuts) 150 grams (5.5 ounces) seeds (I use a mix of pumpkin, sunflower, sesame, and flaxseeds) 1 tablespoon ground cinnamon, nutmeg, ginger, or cardamom (or a mix) (optional) 50 grams (5 tablespoons/1.75 ounces) coconut oil 100 grams (1⁄3 cup/3.5 ounces) maple syrup 4 tablespoons almond or peanut butter (optional) 75 grams (2.75 ounces) organic* dried fruit, roughly chopped (I use a mix of dried apricots, figs, dates, cranberries, and sour cherries) Sea salt *Select organic dried fruit to ensure it doesn't contain additives like sulphur dioxide Method: 1. Preheat the oven to 160°C/140°C fan/325°F and line your largest baking sheet with baking paper. 2. Mix all the dry ingredients in a large bowl. 3. Melt the coconut oil in a small saucepan over a low heat (or melt in the microwave for 30 seconds). Stir in the maple syrup, nut butter (if using), and a pinch of salt, then mix until fully combined. Pour over the dry ingredients and stir until everything is nicely coated. 4. Spread out in an even layer on the baking sheet and bake for 30 to 35 minutes until golden, stirring and tossing occasionally so that it cooks evenly. 5. Leave to cool on the tray, then stir in the dried fruit. 6. Store in an airtight container at room temperature for up to one week. Note: You can cook this using your air fryer too. Heat the air fryer to 160°C/325°F and air fry for 10 to 12 minutes, tossing occasionally. You may need to air fry the granola in two batches depending on the size of your air fryer, for ultimate crispness. It will crisp up further as it cools. Chocolate, peanut, and date bars "Sticky, nutty, and chocolatey, these are the ultimate pick-me-up. You can slice these into smaller bars if you like, but be aware that you may need a little more chocolate to coat all of them. In the summer, I love to eat these straight out of the freezer sprinkled with a tiny pinch of flaky salt," Lambert said. Makes about 15 bars Cook: five minutes Nutrition per bar: Fibre: 3.3 grams Protein: 5 grams Ingredients: 75 grams (3⁄4 cup/2.75 ounces) jumbo or rolled oats 300 grams (10.5 ounces) pitted Medjool dates 4 tablespoons smooth peanut butter 1.5 teaspoons vanilla extract 0.25 teaspoon sea salt 80 grams (2.75 ounces) unsalted roasted peanuts 175 grams (6.25 ounces) dark (bittersweet) chocolate (at least 75% cocoa solids), broken into small pieces 2 teaspoons coconut oil 1. Line a 20-centimeter (8-inch) square cake pan with baking paper, with plenty of overhang. Place the oats in a blender or food processor and blitz to a fine flour, then tip into a bowl and set aside. 2. Place the dates in the blender or food processor (no need to clean it) with the peanut butter, vanilla, and salt. Roughly blitz, then slowly add 75 milliliters (five tablespoons/2.5 fluid ounces) of water until you have a smooth, thick paste. Be sure to scrape down the sides occasionally. Remove 300 grams (10.5 ounces) of the date mix to a bowl and set aside. 3. Add the oat flour back to the blender or food processor with the remaining date mix and pulse a few times until it's nicely combined. Tip the mixture into the base of the lined pan and use wet fingertips to spread it into a smooth layer that fills the tin. 4. Spread the remaining date mixture on top, smoothing it with a spatula. Evenly sprinkle over the nuts, pushing them in a little. Place in the freezer for at least six hours or ideally overnight until frozen and firm. 5. Lift the frozen slab out of the pan and slice into 15 bars. Line a baking sheet with baking paper. 6. Add the chocolate and coconut oil to a heatproof bowl set over a pan of barely simmering water and heat until just melted, stirring to combine. Alternatively, heat in a microwave on the lowest setting in 30-second blasts, stirring between each, until just melted. If you have a cooking thermometer, the chocolate is ready when it reads 45 to 50°C (113 to 122°F). 7. Working one at a time, submerge the bars in the melted chocolate, using two forks to turn them. Lift out of the bowl using the forks, allowing the excess chocolate to drip back into the bowl, then transfer them to the lined sheet. Once all the bars are coated in chocolate, return the sheet to the freezer or fridge for at least 15 minutes until the chocolate is set. Store in an airtight container in the fridge for up to two weeks or freezer for up to four weeks, but I assure you they won't last long! Note: If you can't find roasted peanuts, simply use unroasted peanuts and roast them in the oven at 180°/160°fan/350°F for eight to 12 minutes until golden. Then use in the recipe as specified.